Literature DB >> 3491989

Cross-reactivity to human T-lymphotropic virus type III/lymphadenopathy-associated virus and molecular cloning of simian T-cell lymphotropic virus type III from African green monkeys.

V Hirsch, N Riedel, H Kornfeld, P J Kanki, M Essex, J I Mullins.   

Abstract

Simian T-lymphotropic retroviruses with structural, antigenic, and cytopathic features similar to the etiologic agent of human acquired immunodeficiency syndrome, human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV), have been isolated from a variety of primate species including African green monkeys (STLV-IIIAGM). This report describes nucleic acid cross-reactivity between STLV-IIIAGM and HTLV-III/LAV, molecular cloning of the STLV-IIIAGM genome, and evaluation of its structure and genetic relationship to other retroviruses. Overlapping clones from a cell line infected with virus from a single animal were found to encompass the entire STLV-IIIAGM genome and exhibit a limited degree of restriction-site variability. Specific hybridizing fragments were detected in DNA from this and other STLV-IIIAGM-infected cell lines. A fraction of viral DNA present in at least two STLV-IIIAGM lines persists as unintegrated viral DNA, a characteristic of infection with cytopathic retroviruses. Strongest cross-reactivity was detected between HTLV-III/LAV pol- and gag- genes and STLV-IIIAGM, whereas no cross-reactivity was detected between STLV-IIIAGM and molecular clones of human T-lymphotropic virus types I and II (HTLV-I and -II), visna virus, bovine leukemia virus, or feline leukemia virus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3491989      PMCID: PMC387219          DOI: 10.1073/pnas.83.24.9754

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Natural adult T-cell leukemia virus infection in Japanese monkeys.

Authors:  I Miyoshi; S Yoshimoto; M Fujishita; H Taguchi; I Kubonishi; K Niiya; M Minezawa
Journal:  Lancet       Date:  1982-09-18       Impact factor: 79.321

2.  A bacteriophage lambda vector for cloning large DNA fragments made with several restriction enzymes.

Authors:  W A Loenen; W J Brammar
Journal:  Gene       Date:  1980-08       Impact factor: 3.688

3.  Molecular cloning of a unique human T-cell leukemia virus (HTLV-IIMo).

Authors:  E P Gelmann; G Franchini; V Manzari; F Wong-Staal; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

4.  A new type D retrovirus isolated from macaques with an immunodeficiency syndrome.

Authors:  M D Daniel; N W King; N L Letvin; R D Hunt; P K Sehgal; R C Desrosiers
Journal:  Science       Date:  1984-02-10       Impact factor: 47.728

5.  Transformation of human umbilical cord blood T cells by human T-cell leukemia/lymphoma virus.

Authors:  M Popovic; G Lange-Wantzin; P S Sarin; D Mann; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

6.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

7.  Prevalence of antibody to adult T-cell leukemia virus-associated antigens (ATLA) in Japanese monkeys and other non-human primates.

Authors:  M Hayami; A Komuro; K Nozawa; T Shotake; K Ishikawa; K Yamamoto; T Ishida; S Honjo; Y Hinuma
Journal:  Int J Cancer       Date:  1984-02-15       Impact factor: 7.396

8.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

9.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

10.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more
  10 in total

1.  Molecular cloning of two west African human immunodeficiency virus type 2 isolates that replicate well in macrophages: a Gambian isolate, from a patient with neurologic acquired immunodeficiency syndrome, and a highly divergent Ghanian isolate.

Authors:  H Kühnel; H von Briesen; U Dietrich; M Adamski; D Mix; L Biesert; R Kreutz; A Immelmann; K Henco; C Meichsner
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

2.  Functional comparison of transactivation by simian immunodeficiency virus from rhesus macaques and human immunodeficiency virus type 1.

Authors:  G A Viglianti; J I Mullins
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

3.  Molecular characterization of a new mosaic Simian Immunodeficiency Virus in a naturally infected tantalus monkey (Chlorocebus tantalus) from Cameroon: a challenge to the virus-host co-evolution of SIVagm in African green monkeys.

Authors:  Ahidjo Ayouba; Richard Njouom; Julius Ebua Chia; Steve Ahuka-Mundeke; Anfumbom Kfutwah; Eitel Mpoudi Ngole; Eric Nerrienet; Eric Delaporte; Martine Peeters
Journal:  Infect Genet Evol       Date:  2014-12-11       Impact factor: 3.342

4.  Isolation and characterization of simian immunodeficiency virus from mandrills in Africa and its relationship to other human and simian immunodeficiency viruses.

Authors:  H Tsujimoto; R W Cooper; T Kodama; M Fukasawa; T Miura; Y Ohta; K Ishikawa; M Nakai; E Frost; G E Roelants
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

5.  Inoculation of baboons and macaques with simian immunodeficiency virus/Mne, a primate lentivirus closely related to human immunodeficiency virus type 2.

Authors:  R E Benveniste; W R Morton; E A Clark; C C Tsai; H D Ochs; J M Ward; L Kuller; W B Knott; R W Hill; M J Gale
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

6.  Regions required for CD4 binding in the external glycoprotein gp120 of simian immunodeficiency virus.

Authors:  C B Doyle; U Bhattacharyya; K A Kent; J E Stott; I M Jones
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

7.  Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of west-central African origin.

Authors:  R De Leys; B Vanderborght; M Vanden Haesevelde; L Heyndrickx; A van Geel; C Wauters; R Bernaerts; E Saman; P Nijs; B Willems
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

8.  The specificity of the human immunodeficiency virus type 2 transactivator is different from that of human immunodeficiency virus type 1.

Authors:  M Emerman; M Guyader; L Montagnier; D Baltimore; M A Muesing
Journal:  EMBO J       Date:  1987-12-01       Impact factor: 11.598

Review 9.  The evolution of HIV: inferences using phylogenetics.

Authors:  Eduardo Castro-Nallar; Marcos Pérez-Losada; Gregory F Burton; Keith A Crandall
Journal:  Mol Phylogenet Evol       Date:  2011-11-27       Impact factor: 4.286

10.  A novel medium-throughput biological assay system for HTLV-1 infectivity and drug discovery.

Authors:  Mojtaba Fattahi Abdizadeh; Manoochehr Makvandi; Alireza Samarbafzadeh; Kayhan Azadmanesh
Journal:  Iran J Basic Med Sci       Date:  2017-10       Impact factor: 2.699

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.